#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Short stature Uveal melanoma Anti-HLA antibody test positive Spinal cord injury B-cell small lymphocytic lymphoma recurrent Ovarian cancer stage IV Haemophagocytic lymphohistiocytosis Von Hippel-Lindau disease Spina bifida Macular telangiectasia Cystic fibrosis lung Colitis ulcerative Hypotransferrinaemia Neuroendocrine carcinoma More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Diagnostics Breast angiosarcoma metastatic Short-bowel syndrome – Life with Disease Paroxysmal nocturnal haemoglobinuria – Treatment Haemophilia B with anti factor IX Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Lymphangioma – Treatment Pleomorphic leiomyosarcoma – Diagnostics Rett syndrome – Life with Disease Haemophilia B with anti factor IX – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ripasudil Tabelecleucel Cladribine CC-97540 Adagrasib Methohexital Sodium Empasiprubart SODIUM SULFIDE NONAHYDRATE Aluminium Oxide, Hydrated Clioquinol Arginine Foscarnet Sodium Hexahydrate Etrumadenant Quavonlimab [11C]Az14193391 Oseltamivir Oxitriptan Etelcalcetide Cl-Ad-Msc-002 Mk-0482 More therapies…

    Learn about Your Condition

    Hepatic fibrosis Thrombocytosis Hypochromic anaemia Petit mal epilepsy Pyoderma gangrenosum Sickle cell anaemia Cachexia Malignant peritoneal neoplasm Acoustic neuroma Red blood cell abnormality Clinically isolated syndrome Merycism Bile duct adenocarcinoma Aortic valve stenosis Von Hippel-Lindau disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mantle cell lymphoma

  • Study on the Effectiveness and Safety of Ibrutinib and Rituximab for Patients with Indolent Mantle Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Rituximab
    Spain

  • Study of Ibrutinib and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Bortezomib
    • Lenalidomide
    Czechia Poland Spain

  • Study of Glofitamab and Obinutuzumab for Patients with Relapsed or Refractory Lymphomas After CAR T-cell Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • Diffuse large B-cell lymphoma
    • Mantle cell lymphoma
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    France

  • Study of Acalabrutinib, Venetoclax, and Rituximab for Patients with Newly Diagnosed Mantle Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Acalabrutinib
    • Rituximab
    • Venetoclax
    Poland Spain

  • Study on KTE-X19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma Responding Partially to Ibrutinib

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma recurrent
    • Mantle cell lymphoma refractory
    • Mantle cell lymphoma
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Brexucabtagene Autoleucel
    • Fludarabine
    Italy

  • Study on Obinutuzumab, Venetoclax, and Ibrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Ibrutinib
    • Obinutuzumab
    • Venetoclax
    France
Previous Page
1 … 3 4 5

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!